3D bioprinted human tissue sales will expand through 2035, with hospitals at 32.9% of the end user category in 2025. The market was valued at USD 2,373.0 million in 2025, is projected to reach USD 3,526.2 million by 2035 and is forecast to record a 4.0% CAGR between 2025 and 2035.